INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

412 studies · page 10 of 18

2013 / Randomized double-blind controlled clinical trial

Brewer's yeast supplementation significantly improved fasting blood sugar, HbA1c, and insulin sensitivity in adults with type 2 diabetes.

In a randomized double-blind controlled trial, 84 adults with type 2 diabetes were assigned to receive either brewer's yeast (1800 mg/day as six 300 mg tablets) or a placebo for 12 weeks. Changes in fasting blood sugar, glycosylated hemoglobin, and insulin sensitivity were significantly different between groups (P < 0.001, P < 0.001, and P = 0.02, respectively). Differences remained statistically significant at the end of the study after adjusting for baseline values (P = 0.002, P < 0.001, and P = 0.02). Changes in body mass index, 24-hour food record, and insulin resistance were not significant.

Hosseinzadeh P, Javanbakht MH, Mostafavi SA, et al. Int J Prev Med, 2013. PMID 24319552

2013 / Randomized double-blind controlled trial

Strawberry supplementation reduced inflammation and oxidative stress in adults with type 2 diabetes.

Thirty-six adults with type 2 diabetes consumed either 50 grams of freeze-dried strawberry powder or a flavor-matched placebo daily for 6 weeks. Strawberry supplementation significantly reduced C-reactive protein from 2.5 to 2.04 mg/l and malondialdehyde from 3.36 to 2.7 nmol/ml compared to baseline. It also raised total antioxidant status (1.44 vs. 1.26 mmol/l) and decreased HbA1c by 5.7% compared with placebo, without affecting glucose or body measurements.

Moazen S, Amani R, Homayouni Rad A, et al. Ann Nutr Metab, 2013. PMID 24334868

2013 / Interventional study

A 7-day modified fast reduced weight, lowered blood pressure, improved metabolic markers, and enhanced mood in women with and without metabolic syndrome.

Thirty female subjects with or without metabolic syndrome underwent a 7-day Buchinger modified fast providing 300 kcal/day. Mean weight decreased from 85.4 ± 18.8 kg to 79.7 ± 18.2 kg, with systolic and diastolic blood pressure reductions of -16.2 mm Hg (95% CI: -9.1; -23.3 mm Hg, p < 0.001) and -6.0 mm Hg (95% CI: -1.8; -10.3 mm Hg, p = 0.005). Fasting also decreased LDL-cholesterol, leptin, and insulin, increased adiponectin, leptin receptors, and resistin, and improved mood scores (decreased anxiety, depression, fatigue, and improved vigor).

Li C, Ostermann T, Hardt M, et al. Forsch Komplementmed, 2013. PMID 24434755

2013 / Randomized crossover feeding trial

Adding almonds or sunflower kernels to a recommended diet lowered total and LDL cholesterol in postmenopausal women with type 2 diabetes.

In a randomized crossover feeding study, 22 postmenopausal women with type 2 diabetes consumed personalized diets supplemented with 30 g/d of either almonds (AD) or sunflower kernels (SKD) for two 3-week periods separated by a 4-week washout. Compared to the AD, the SKD led to a significant reduction in HDL-C, triacylglycerol (TAG), apolipoprotein A1, and apolipoprotein B100. Total cholesterol and LDL-C decreased significantly from baseline on both diets, with no significant difference observed between the diets.

Richmond K, Williams S, Mann J, et al. ISRN Nutr, 2013. PMID 24959542

2012 / Randomized crossover trial

Ingestion of 6 g Ceylon cinnamon did not significantly affect postprandial glucose, insulin response, GI, or GII in subjects with impaired glucose tolerance.

A crossover trial assessed 10 subjects with impaired glucose tolerance receiving a standard 75 g oral glucose tolerance test with either placebo or Cinnamomum zeylanicum (Ceylon cinnamon) capsules. Blood samples were measured before and up to 180 minutes post-test. Ingestion of 6 g C. zeylanicum had no significant effect on glucose level, insulin response, glycaemic index, or insulinaemic index.

Wickenberg J, Lindstedt S, Berntorp K, et al. Br J Nutr, 2012. PMID 21929834

2012 / Controlled feeding study

Late high-glycemic-index meals were linked to worse glucose tolerance and insulin sensitivity.

Six healthy lean volunteers ate isoenergetic meals across four occasions, testing high- or low-glycemic index foods consumed predominantly early or late. Peak glucose levels occurred following large 5021 kJ high-glycemic index suppers, with significantly elevated glucose for late high- versus low-glycemic meals (P < 0.01). Estimates of postprandial insulin sensitivity were substantially worse when high energy intake was consumed during the evening meal.

Morgan LM, Shi JW, Hampton SM, et al. Br J Nutr, 2012. PMID 22176632

2012 / Acute postprandial clinical trial

A high-fat meal significantly increased circulating endotoxin levels, with higher postprandial levels observed in type 2 diabetic subjects.

Fifty-four subjects across four metabolic groups (nonobese controls, obese, impaired glucose tolerance [IGT], and type 2 diabetic) consumed a high-fat meal (75 g fat, 5 g carbohydrate, 6 g protein) after an overnight fast. Baseline circulating endotoxin was 60.6% higher in type 2 diabetic subjects than in nonobese controls (P < 0.05). Ingestion of the high-fat meal led to a significant increase in endotoxin levels over 4 hours in type 2 diabetic, IGT, and obese subjects (P < 0.05), with 4-hour levels 125.4% higher in type 2 diabetic subjects than nonobese controls (P < 0.05).

Harte AL, Varma MC, Tripathi G, et al. Diabetes Care, 2012. PMID 22210577

2012 / Interventional study

Epicatechin-rich cocoa improved skeletal muscle mitochondrial structure and biogenesis markers in patients with type 2 diabetes and heart failure.

Five patients with type 2 diabetes and stage II/III heart failure consumed dark chocolate and a beverage providing approximately 100 mg of (-)-epicatechin per day for 3 months. Skeletal muscle was assessed for mitochondrial structure and molecular markers of biogenesis. Treatment increased the protein and/or activity of biogenesis mediators and cristae abundance, without altering mitochondrial volume density.

Taub PR, Ramirez-Sanchez I, Ciaraldi TP, et al. Clin Transl Sci, 2012. PMID 22376256

2012 / Randomized crossover trial

Peach shake intake increased circulating salicylic acid and altered metabolic responses compared to sugar

In a randomized crossover study, 26 healthy participants consumed a peach shake meal or a mixed sugar solution matched for fruit sugars. Salicylic acid peaked at 90 minutes with both prior fruit restriction (0.18 ± 0.01 µmol/L) and usual diet (0.38 ± 0.02 µmol/L). The peach shake led to smaller glucose excursions (p < 0.05), greater declines in free fatty acids (p < 0.01), and smaller rises in interleukin-6 (p < 0.05).

Rinelli S, Spadafranca A, Fiorillo G, et al. Plant Foods Hum Nutr, 2012. PMID 22392497

2012 / Randomized, double-blind pilot trial

Weaning to bovine insulin-free cow's milk formula reduced the cumulative incidence of diabetes autoantibodies by age 3 in genetically at-risk infants.

The FINDIA pilot trial tested whether weaning infants genetically susceptible to type 1 diabetes to a bovine insulin-free cow's milk formula (FINDIA formula), a whey-based hydrolyzed formula (WHF), or ordinary cow's milk formula (CMF) for the first 6 months reduced beta-cell autoimmunity. In the intention-to-treat analysis, 2.6% in the FINDIA group, 4.9% in the WHF group, and 6.3% in the CMF group were positive for at least 1 autoantibody by age 3 years. Compared to CMF, the odds ratio was 0.39 (95% CI, 0.17-0.91) for the FINDIA formula and 0.75 (95% CI, 0.37-1.54) for WHF. In the treatment-received analysis, the odds ratios were 0.23 (95% CI, 0.08-0.69) for FINDIA formula and 0.81 (95% CI, 0.37-1.76) for WHF.

Vaarala O, Ilonen J, Ruohtula T, et al. Arch Pediatr Adolesc Med, 2012. PMID 22393174

2012 / Randomized controlled trial

Daily pistachio consumption for twelve weeks did not cause weight gain in metabolic syndrome.

Ninety adults with metabolic syndrome on an American Heart Association Step I diet were randomized to 42 g/day, 70 g/day, or no pistachios for 12 weeks. Neither pistachio dose led to significant alterations in body weight, body mass index, or waist-to-hip ratio compared to control or baseline. At week 12, post-challenge glucose decreased significantly from baseline in the 70 g group (-1.13 ± 2.58 mmol/L, p = 0.02).

Wang X, Li Z, Liu Y, et al. Nutr J, 2012. PMID 22472037

2012 / Randomized crossover trial

In overweight and obese men, sprouted-grain bread reduced postprandial glycemic response compared to other test breads.

Overweight or obese males ingested 11-grain, sprouted-grain, 12-grain, sourdough, or white bread matched for available carbohydrate (50 g, n = 12) in part 1 and matched for bread mass (107 g, n = 11) in part 2. In part 1, glucose response for sprouted-grain was lower than 11-grain, sourdough, and white breads, while sourdough had a lower GLP-1 response than all breads and lower insulin AUC than 11-grain and sprouted-grain breads. In part 2, glucose and insulin AUC for sourdough were greater than 11-grain, sprouted-grain, and 12-grain breads. Overall, sprouted-grain bread reduced the glycemic response in both parts, whereas other whole-grain test breads did not improve acute postprandial metabolic responses.

Mofidi A, Ferraro ZM, Stewart KA, et al. J Nutr Metab, 2012. PMID 22474577

2012 / Randomized controlled trial follow-up

Lifestyle intervention did not affect leukocyte telomere length, which increased in about two thirds of participants regardless of study group.

Researchers evaluated leukocyte telomere length (TL) at two time points on average 4.5 years apart in the Finnish Diabetes Prevention Study (N=334 and 343). TL was inversely correlated with age and increased in about two thirds of individuals in both the intervention and control groups, increasing most in those with the shortest baseline TL. The lifestyle intervention had no effect on TL, and TL was not associated with the development of type 2 diabetes, insulin secretion, or insulin resistance indices.

Hovatta I, de Mello VD, Kananen L, et al. PLoS One, 2012. PMID 22493726

2012 / Randomized 4x4 crossover trial

Combining pinto, black, or red kidney beans with rice reduced postprandial glycemic response compared to rice alone in adults with type 2 diabetes.

A randomized 4x4 crossover trial evaluated postprandial glycemic responses to meals of white long grain rice alone versus pinto beans/rice, black beans/rice, and red kidney beans/rice (each matched for 50 grams of available carbohydrate) in 17 adults with type 2 diabetes. Postprandial net glucose values were significantly lower for all three bean/rice treatments compared to the rice control at 90, 120, and 150 minutes. Incremental area under the curve values were significantly lower for pinto and black bean/rice meals compared to rice alone, but not for kidney beans.

Thompson SV, Winham DM, Hutchins AM Nutr J, 2012. PMID 22494488

2012 / Randomized double-blind clinical trial

Broccoli sprouts powder may improve insulin resistance in type 2 diabetic patients.

Eighty-one type 2 diabetic patients were randomly assigned to receive 10 g/d broccoli sprouts powder (BSP), 5 g/d BSP, or placebo for 4 weeks, with 63 included in the analysis. After 4 weeks, consumption of 10 g/d BSP resulted in a significant decrease in serum insulin concentration and HOMA-IR (p = 0.05 for treatment effect). Fasting serum glucose and glucose-to-insulin ratio were also measured. The authors concluded that broccoli sprouts may improve insulin resistance in type 2 diabetic patients.

Bahadoran Z, Tohidi M, Nazeri P, et al. Int J Food Sci Nutr, 2012. PMID 22537070

2012 / Non-randomized clinical trial

A ketogenic diet improved glycemic control more than a low-calorie diet in diabetes.

In a 24-week dietary intervention, 363 overweight and obese adults (102 with type 2 diabetes) self-selected either a low-calorie diet or a low-carbohydrate ketogenic diet. Both dietary regimens improved anthropometrics, blood lipids, and glycemic indicators across the intervention period. The observed improvements were significantly greater in participants following the ketogenic diet than in those consuming the low-calorie diet, while creatinine remained unchanged.

Hussain TA, Mathew TC, Dashti AA, et al. Nutrition, 2012. PMID 22673594

2012 / Comparative longitudinal intervention study

Two weeks of daily supervised exercise significantly increased serum FGF21 levels in sedentary young healthy women.

Sixty sedentary healthy young women participated in a longitudinal study evaluating anthropometric and biochemical parameters before and after a bout of exercise and after two weeks of daily supervised exercise. Anthropometric characteristics did not change, but FGF21 levels significantly increased from 276.8 ng/l (142.8-568.6) to 460.8 ng/l (298.2-742.1) (p<0.0001). The change in serum FGF21 positively correlated with basal glucose, mean maximal heart rate, mean METs, delta plasma epinephrine, and delta plasma free fatty acids, which were independently associated with the FGF21 increase in regression analysis (F=4.32; r²=0.64, p<0.0001).

Cuevas-Ramos D, Almeda-Valdés P, Meza-Arana CE, et al. PLoS One, 2012. PMID 22701542

2012 / Randomized, double-blind, placebo-controlled trial

A 9-month curcumin intervention prevented progression to type 2 diabetes and improved β-cell function in people with prediabetes.

A randomized, double-blinded, placebo-controlled trial assigned 240 prediabetic subjects to receive curcumin or placebo capsules for 9 months. After 9 months, 16.4% of subjects in the placebo group were diagnosed with type 2 diabetes mellitus, compared to none in the curcumin-treated group. The curcumin group also demonstrated significantly higher HOMA-β (61.58 vs. 48.72; P < 0.01), lower C-peptide (1.7 vs. 2.17; P < 0.05), lower HOMA-IR (3.22 vs. 4.04; P < 0.001), and higher adiponectin (22.46 vs. 18.45; P < 0.05) compared to placebo, with very minor adverse effects reported.

Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, et al. Diabetes Care, 2012. PMID 22773702

2012 / Randomized crossover trial

Blackcurrants and lingonberries blunted the postprandial glucose and insulin response to sucrose.

In a randomized crossover trial, 20 healthy women ingested 35 g sucrose alone or alongside 150 g purées or 300 mL nectars of blackcurrants or lingonberries. Consuming sucrose with whole berries decreased glucose and insulin levels over the initial 30 minutes and slowed the drop during the second hour. Whole berries and nectars both prevented late postprandial hypoglycemia and the rebound of free fatty acids seen with sucrose alone.

Törrönen R, Kolehmainen M, Sarkkinen E, et al. Am J Clin Nutr, 2012. PMID 22854401

2012 / Comparative intervention trial

Consuming five cups of pulses weekly for 8 weeks reduced metabolic syndrome risk factors similarly to energy-restriction counseling in overweight/obese adults.

Researchers compared the effects of eating five cups/week of pulses (yellow peas, chickpeas, navy beans, and lentils) versus counseling to reduce energy intake by 500 kcal/d over 8 weeks in overweight or obese adults. At week 8, both groups showed reductions in energy intake, waist circumference, systolic blood pressure, HbA1c, glucose AUC, and HOMA-IR (P < 0.05). HDL and fasting C-peptide responses differed by diet (P < 0.05): HDL rose by 4.5% and C-peptide by 12.3% in the pulse group, but decreased by 0.8% and 7.6% in the energy-restricted group. Insulin AUC decreased on the energy-restricted diet by 24.2% in females and 4.8% in males, while on the pulse diet it decreased by 13.9% in females and increased by 27.3% in males (P < 0.05).

Mollard RC, Luhovyy BL, Panahi S, et al. Br J Nutr, 2012. PMID 22916807

2012 / Randomized controlled trial

A 21-day Daniel Fast improved cardiometabolic markers and body weight in men and women, with no additional effect from krill oil supplementation.

Participants followed a 21-day Daniel Fast dietary plan randomized to either 2 g/day of krill oil or 2 g/day of coconut oil placebo. Krill oil supplementation showed no significant effect on any outcome (p > 0.05), so groups were collapsed. Following the 21-day fast, participants experienced significant decreases in LDL-C (100.6 ± 4.3 vs. 80.0 ± 3.7 mg/dL), LDL:HDL ratio (2.0 ± 0.1 vs. 1.7 ± 0.1), fasting glucose (101.4 ± 7.5 vs. 91.7 ± 3.4 mg/dL), fasting insulin (7.92 ± 0.80 vs. 5.76 ± 0.59 μU/mL), HOMA-IR (2.06 ± 0.30 vs. 1.40 ± 0.21), systolic BP (110.7 ± 2.2 vs. 105.5 ± 1.7 mm Hg), and body weight (74.1 ± 2.4 vs. 71.5 ± 2.3 kg; all p < 0.05).

Trepanowski JF, Kabir MM, Alleman RJ, et al. Nutr Metab (Lond), 2012. PMID 22971786

2012 / Randomized controlled trial

Daily milk protein beverages increased BMI-for-age Z-scores in overweight adolescents.

In a 12-week randomized trial, 203 overweight adolescents aged 12-15 years consumed 1 L daily of skim milk, whey, casein, or water. BMI-for-age Z-scores increased after 12 weeks in all three dairy protein groups compared to baseline, water, and pretest controls. In addition, plasma C-peptide concentrations increased significantly from baseline in the whey and casein groups (P < 0.02 vs pretest control), but did not change in the skim milk group.

Arnberg K, Mølgaard C, Michaelsen KF, et al. J Nutr, 2012. PMID 23077192

2012 / Randomized controlled trial

A low-GI legume diet reduced HbA1c and calculated CHD risk more than a high wheat fiber diet in type 2 diabetes.

A randomized trial assigned 121 participants with type 2 diabetes to either a low-GI legume diet (encouraging an increase of at least 1 cup of legumes per day) or a high wheat fiber diet for 3 months. The low-GI legume diet reduced HbA1c by -0.5% (95% CI, -0.6% to -0.4%) compared to -0.3% (95% CI, -0.4% to -0.2%) on the high wheat fiber diet, yielding a greater relative reduction of -0.2% (95% CI, -0.3% to -0.1%; P < .001). The relative CHD risk reduction on the low-GI legume diet was -0.8% (95% CI, -1.4% to -0.3%; P = .003), largely driven by a greater relative reduction in systolic blood pressure of -4.5 mm Hg (95% CI, -7.0 to -2.1 mm Hg; P < .001).

Jenkins DJ, Kendall CW, Augustin LS, et al. Arch Intern Med, 2012. PMID 23089999

2012 / Interventional trial (21 days institutional, up to 3 months home-based)

A Ma-Pi 2 macrobiotic diet reduced blood pressure, biochemical indicators, and insulin consumption in type 2 diabetic adults.

Sixty-five type 2 diabetic adults underwent a Ma-Pi 2 macrobiotic diet intervention for 21 days institutionally, followed by home-based adherence up to 3 months (54 completed). During the intervention, energy intake was 200 kcal higher due to more complex carbohydrates and dietary fiber, despite less fat and protein. Blood pressure and serum biochemical indicators decreased significantly in both periods, while safety indicators (hemoglobin, total proteins, albumin) did not vary. Global cardiovascular risk decreased, and insulin consumption dropped by 46% and 64% in the short- and medium-term periods, respectively.

Porrata-Maury C, Hernández-Triana M, Rodríguez-Sotero E, et al. J Nutr Metab, 2012. PMID 23097695